MINNEAPOLIS & INDIANAPOLIS--(BUSINESS WIRE)--Two of the most recognized names in diabetes management – Medtronic, Inc. (NYSE:MDT) and Eli Lilly and Company (NYSE:LLY) – today announced a strategic marketing collaboration to bolster each company’s commitment to help people with diabetes manage their blood sugar using insulin therapy.
